[go: up one dir, main page]

WO2007135518A3 - Emploi de préparations à base de choline dans le traitement de l'acouphène - Google Patents

Emploi de préparations à base de choline dans le traitement de l'acouphène Download PDF

Info

Publication number
WO2007135518A3
WO2007135518A3 PCT/IB2007/001273 IB2007001273W WO2007135518A3 WO 2007135518 A3 WO2007135518 A3 WO 2007135518A3 IB 2007001273 W IB2007001273 W IB 2007001273W WO 2007135518 A3 WO2007135518 A3 WO 2007135518A3
Authority
WO
WIPO (PCT)
Prior art keywords
tinnitus
choline
treatment
based preparations
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/001273
Other languages
English (en)
Other versions
WO2007135518A2 (fr
Inventor
Massimo Ronchetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARTMED Srl
Original Assignee
ARTMED Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARTMED Srl filed Critical ARTMED Srl
Priority to EP07734581A priority Critical patent/EP2026786A2/fr
Publication of WO2007135518A2 publication Critical patent/WO2007135518A2/fr
Publication of WO2007135518A3 publication Critical patent/WO2007135518A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne l'emploi de compositions à base de choline et d'acides gras polyinsaturés dans le traitement prophylactique et thérapeutique de l'acouphène.
PCT/IB2007/001273 2006-05-16 2007-05-16 Emploi de préparations à base de choline dans le traitement de l'acouphène Ceased WO2007135518A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07734581A EP2026786A2 (fr) 2006-05-16 2007-05-16 Emploi de préparations à base de choline dans le traitement de l'acouphène

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000956A ITMI20060956A1 (it) 2006-05-16 2006-05-16 Uso di composizioni a base di colina per il trattamento del tinnito
ITMI2006A000956 2006-05-16

Publications (2)

Publication Number Publication Date
WO2007135518A2 WO2007135518A2 (fr) 2007-11-29
WO2007135518A3 true WO2007135518A3 (fr) 2008-02-07

Family

ID=38610962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001273 Ceased WO2007135518A2 (fr) 2006-05-16 2007-05-16 Emploi de préparations à base de choline dans le traitement de l'acouphène

Country Status (3)

Country Link
EP (1) EP2026786A2 (fr)
IT (1) ITMI20060956A1 (fr)
WO (1) WO2007135518A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
GB201609735D0 (en) * 2016-06-03 2016-07-20 Avexxin As Combination therapy
CA3037582A1 (fr) 2016-09-21 2018-03-29 Avexxin As Composition pharmaceutique

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084882A1 (fr) * 2003-03-27 2004-10-07 Suntory Limited Utilisation de l’acide arachidonique pour normaliser le rythme infradien

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084882A1 (fr) * 2003-03-27 2004-10-07 Suntory Limited Utilisation de l’acide arachidonique pour normaliser le rythme infradien

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAKISHIMA K ET AL: "TREATMENT OF SENSORY-NEURAL DEAFNESS AND TINNITUS WITH A NUCLEIC ACID DERIVATIVE A CLINICAL EVALUATION OF CDP-CHOLINE BY A DOUBLE-BLIND METHOD", 1971, ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, PAGE(S) 1343-1349, ISSN: 0004-4172, XP001002631 *

Also Published As

Publication number Publication date
ITMI20060956A1 (it) 2007-11-17
EP2026786A2 (fr) 2009-02-25
WO2007135518A2 (fr) 2007-11-29

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
WO2007008586A3 (fr) Acides gras polyinsatures pour le traitement de la demence et d'etats predementiels
GB2459809A (en) Fatty acid formulations and methods of use thereof
IL196465A0 (en) Compositions and methods for the treatment of mucositis
WO2007095316A3 (fr) Compositions et procédés pour formulations à base d'oligonucléotides
WO2008036353A3 (fr) Émulsions de diglycérides oméga-3
WO2012074930A3 (fr) Composition à faible éructation et méthodes de traitement et/ou de prévention de maladie cardiovasculaire chez un sujet présentant une allergie/hypersensibilité aux poissons
MY152880A (en) Use of dpa(n-6) oils in infant formula
UA108850C2 (uk) Екстракт цілісного насіння видів moringa та його застосування у косметичній та/або дерматологічній композиції
IL196282A0 (en) Compositions and methods for enhancing the efficacy of il-2 mediated immune responses
WO2007001851A3 (fr) Préparations et méthodes pour le diagnostic et le traitement d'une tumeur
ZA200802457B (en) Method for extending the shelf-life of food compositions containing polyunsaturated fatty acids
WO2009026574A3 (fr) Compositions immunogènes et leurs utilisations
WO2012013331A3 (fr) Capsules d'ingrédients pharmaceutiques actifs et d'acides gras polyinsaturés pour le traitement de maladies de la prostate
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
WO2008139261A9 (fr) Alcools d'acides gras
WO2009125409A3 (fr) Amides d'acides gras et leurs utilisations
WO2008011178A3 (fr) Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente
IL195771A0 (en) Methods and immune modulatory nucleic acid compositions for preventing and treating disease
PL2214628T3 (pl) Kompozycja ulegająca rozpadowi w jamie ustnej, zawierająca wielonienasycone kwasy tłuszczowe bez przykrej woni lub smaku
WO2007135518A3 (fr) Emploi de préparations à base de choline dans le traitement de l'acouphène
WO2011011706A3 (fr) Méthodes et compositions pour le traitement ou la prévention de maladies auto-immunes utilisant des agents immunomodulateurs
SE0201566D0 (sv) New composition
WO2010119034A3 (fr) Composition a base de petrolatum contenant plus de 10% de silicone, presentant des proprietes de toucher ameliorees et une stabilite preservee
WO2008022807A3 (fr) Traitement et prévention de la fibrose intestinale

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07734581

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007734581

Country of ref document: EP